Cardiopulmonary Bypass Copolymer Surface Modification Reduces neither Blood Loss nor Transfusions in Coronary Artery Surgery

References

• 1 Südkamp M, Mehlhorn U, Reza Raji M. et al . Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.  Thoracic Cardiov Surg. 2002;  50 1-4
• 2 Rubens F D, Labow R S, Lavallee G R. et al . Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer.  Ann Thorac Surg. 1999;  67 689-698
• 3 Wachtfogel Y T, Kucich U, Hack C E. et al . Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.  J Thorac Cardiovasc Surg. 1993;  106 1-9
• 4 Blauhut B, Gross C, Necek S, Doran J E, Spath P, Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.  J Thorac Cardiovasc Surg. 1991;  101 958-967
• 5 van Oeveren W, Harder M P, Roozendaal K J, Eijsman L, Wildevuur C R. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.  J Thorac Cardiovasc Surg. 1990;  99 788-796